论文部分内容阅读
对高泌乳素血症患者诊断的主要目标是探索有无垂体腺瘤。在美国,垂体腺瘤的发生率为2,500/年。由于放免测定泌乳素(PRL)的推广和蝶鞍断层摄片的应用,现认为分泌 PRL 的腺瘤占垂体腺瘤中的65~0%,腺瘤体积在10mm 以下者,属于微腺瘤,约占切除腺瘤中的20%。在105例手术切除时发现多数微腺瘤位于垂体两侧,有53例在垂体组织内,直径小于6mm。Ferrari报道在133例高泌乳素血症中(PRL>
The main goal of diagnosis of patients with hyperprolactinemia is to explore whether there is a pituitary adenoma. In the United States, the incidence of pituitary adenomas is 2,500 per year. Because of the determination of radioactive determination of prolactin (PRL) promotion and the application of sella coronary angiography, it is thought that the secretion of PRL adenomas in pituitary adenomas in 65 to 0%, adenoma volume of 10mm or less, are micro-adenoma, About 20% of adenoma excision. In 105 cases of surgical resection found that most of the microadenomas located on both sides of the pituitary, 53 cases in the pituitary tissue, the diameter of less than 6mm. Ferrari reported 133 cases of hyperprolactinemia (PRL>